607 filings
8-K
RSPI
RespireRx Pharmaceuticals Inc.
6 Sep 24
Amendments to Articles of Incorporation or Bylaws
8:45am
8-K
RSPI
RespireRx Pharmaceuticals Inc.
2 Aug 24
Entry into a Material Definitive Agreement
8:30am
8-K
RSPI
RespireRx Pharmaceuticals Inc.
8 Jul 24
Entry into a Material Definitive Agreement
4:01pm
8-K
RSPI
RespireRx Pharmaceuticals Inc.
29 May 24
Regulation FD Disclosure
9:03am
8-K
RSPI
RespireRx Pharmaceuticals Inc.
16 Apr 24
Entry into a Material Definitive Agreement
4:05pm
NT 10-K
9hpcmewmfrhxxrr
1 Apr 24
Notice of late annual filing
4:05pm
8-K
f59uaq31
2 Feb 24
Entry into a Material Definitive Agreement
8:30am
8-K
egyaaaltgl
22 Jan 24
RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
8:45am
8-K
a8enbfkkki5ofw4
11 Dec 23
Entry into a Material Definitive Agreement
8:45am
NT 10-Q
9oz3pfj8
14 Nov 23
Notice of late quarterly filing
4:05pm
8-K
wbj rta0y
12 Oct 23
RespireRx Pharmaceuticals Inc.’s Subsidiary ResolutionRx Ltd Enters into Master Services Agreement for Dronabinol Manufacturing and Related Services
9:00am
8-K
e6zbj3 5god
2 Oct 23
Settlement and Exchange Agreement
8:45am
NT 10-Q
scs2e
14 Aug 23
Notice of late quarterly filing
4:15pm
8-K
3x945t8lwbr
9 Aug 23
RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
8:52am
8-K
it14chf ozo95621hf
13 Jun 23
Template of Form of Phantom Stock Award Agreement
4:10pm
8-K
tsrt83jndrw27ry18
24 May 23
Entry into a Material Definitive Agreement
8:45am
NT 10-Q
cta4ehk lv189ug5
15 May 23
Notice of late quarterly filing
4:05pm